http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2623111-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3fb76e5421c795165edc930cf8768c5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_333a3999e12417032afd0066fe3d7765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f5651e3dca70b5b984f1a99f0de4138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a739f2c80cef34ce44b1b5e6c415dfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c2610b37ec67837ee10bf6a9fe1f417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a86ee41700dbfa1ea25d67d760539d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee24d773e1f74560d86c23433cc4ada
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44913182a3bd44567bfac69db895d598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f395dfdffa4216451ddf41b5b3a88f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e833fe9473962ee3e9a3372ab77c9439
publicationDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2623111-A2
titleOfInvention Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition
abstract This invention refers to new peptides obtained from Rhpalurus junceus scorpion venom, which has a high content of proteins, lipids, carbohydrates, amino acids, inorganic salts and other ions, including peptides as active principles. The invention also includes a formulation used as a drug due to its anticarcinogenic, analgesic and anti-inflammatory properties which improve the quality of life of cancer patients.
priorityDate 2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128851630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129704387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752

Total number of triples: 49.